Title : Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.

Pub. Date : 2011 Dec

PMID : 22093536






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dopamine agonists, catechol-O-methyltransferase inhibitors and monoamine oxidase-B inhibitors are anti-parkinsonian (anti-PD) drugs that have been found to further improve the potency of l-dopa and prevent the onset of motor complications. Levodopa catechol-O-methyltransferase Homo sapiens